MEN1: Epilepsy Pathway Innovation in Africa (EPInA)

This study aims to close prevention, diagnostic and treatment gaps through improving the rate of accurate diagnosis of epilepsy by refining app-based technologies: increase the adherence to medication using text messaging and ensure an enduring, positive change by improving public awareness and reducing the stigma experienced by people living with epilepsy in SSA.

It entails a population-wide survey to estimate the prevalence of epilepsy in two Nairobi slums (Viwandani and Korogocho) followed by a clinical validation of an app for diagnosis of epilepsy by primary health workers and a randomised controlled trial of an SMS-based intervention for improving adherence to anti-epileptic medications. Ethnography is embedded in all these sub-studies.

Project period: January 2020 – January 2025.

Funder: National Institute of Health Research (NIHR-UK)

Partners:

• University of Oxford
• KEMRI Wellcome Trust-Kilifi
• University of Ghana
• Mahenge Epilepsy Center, Tanzania)

Project team:

• Daniel Mtai Mwanga
• Joan Watiri Kinuthia
• Peter Otieno
• Gershim Asiki